Eyenovia Stock Forward View
| EYENDelisted Stock | USD 14.36 1.94 11.90% |
Eyenovia Stock outlook is based on your current time horizon.
The value of RSI of Eyenovia's share price is above 70 as of today suggesting that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Eyenovia, making its price go up or down. Momentum 71
Buy Stretched
Oversold | Overbought |
Using Eyenovia hype-based prediction, you can estimate the value of Eyenovia from the perspective of Eyenovia response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Eyenovia on the next trading day is expected to be 17.34 with a mean absolute deviation of 0.50 and the sum of the absolute errors of 30.52. Eyenovia after-hype prediction price | USD 14.36 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Eyenovia |
Eyenovia Additional Predictive Modules
Most predictive techniques to examine Eyenovia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Eyenovia using various technical indicators. When you analyze Eyenovia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Eyenovia Naive Prediction Price Forecast For the 3rd of February
Given 90 days horizon, the Naive Prediction forecasted value of Eyenovia on the next trading day is expected to be 17.34 with a mean absolute deviation of 0.50, mean absolute percentage error of 0.71, and the sum of the absolute errors of 30.52.Please note that although there have been many attempts to predict Eyenovia Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Eyenovia's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Eyenovia Stock Forecast Pattern
| Backtest Eyenovia | Eyenovia Price Prediction | Research Analysis |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Eyenovia stock data series using in forecasting. Note that when a statistical model is used to represent Eyenovia stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.7629 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.5003 |
| MAPE | Mean absolute percentage error | 0.1293 |
| SAE | Sum of the absolute errors | 30.5167 |
Predictive Modules for Eyenovia
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eyenovia. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eyenovia's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Eyenovia After-Hype Price Density Analysis
As far as predicting the price of Eyenovia at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Eyenovia or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Eyenovia, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Eyenovia Estimiated After-Hype Price Volatility
In the context of predicting Eyenovia's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Eyenovia's historical news coverage. Eyenovia's after-hype downside and upside margins for the prediction period are 14.36 and 14.36, respectively. We have considered Eyenovia's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Eyenovia is very steady at this time. Analysis and calculation of next after-hype price of Eyenovia is based on 3 months time horizon.
Eyenovia Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Eyenovia is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Eyenovia backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Eyenovia, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
14.36 | 14.36 | 0.00 |
|
Eyenovia Hype Timeline
Eyenovia is currently traded for 14.36. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Eyenovia is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Eyenovia is about 0.0%, with the expected price after the next announcement by competition of 14.36. About 13.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 42.65. Eyenovia had not issued any dividends in recent years. The entity had 1:80 split on the 3rd of February 2025. Given the investment horizon of 90 days the next forecasted press release will be in a few days. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.Eyenovia Related Hype Analysis
Having access to credible news sources related to Eyenovia's direct competition is more important than ever and may enhance your ability to predict Eyenovia's future price movements. Getting to know how Eyenovia's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Eyenovia may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CERC | Cerecor | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LUMO | Lumos Pharma | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STSA | Satsuma Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PSTI | Pluristem | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RENB | Renovaro Biosciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LIANY | LianBio | 0.00 | 0 per month | 5.86 | 0.06 | 12.12 | (11.43) | 60.61 | |
| MGTA | Magenta Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MRNS | Marinus Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GRNA | Greenlight Biosciences Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SYRE | Spyre Therapeutics | (0.51) | 9 per month | 2.51 | 0.11 | 7.15 | (4.47) | 20.03 |
Eyenovia Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eyenovia stock to make a market-neutral strategy. Peer analysis of Eyenovia could also be used in its relative valuation, which is a method of valuing Eyenovia by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Eyenovia Market Strength Events
Market strength indicators help investors to evaluate how Eyenovia stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eyenovia shares will generate the highest return on investment. By undertsting and applying Eyenovia stock market strength indicators, traders can identify Eyenovia entry and exit signals to maximize returns.
Story Coverage note for Eyenovia
The number of cover stories for Eyenovia depends on current market conditions and Eyenovia's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Eyenovia is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Eyenovia's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Eyenovia Short Properties
Eyenovia's future price predictability will typically decrease when Eyenovia's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Eyenovia often depends not only on the future outlook of the potential Eyenovia's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eyenovia's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 833 K | |
| Cash And Short Term Investments | 2.1 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Eyenovia Stock
If you are still planning to invest in Eyenovia check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eyenovia's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |